Business & Finance
Merck's board approves higher Q4 dividend & expanded share repurchase plan
26 October 2018 -

The board of directors Merck (NYSE:MRK), a biopharmaceutical company, declared on Thursday its dividend of USD0.55 per share of its outstanding commom stock.

This new dividend marks a growth of 15% from the company's prior quarterly dividend of USD0.48 per share of its outstanding common stock.

Shareholders of record at the close of business as of 17 December 2018 will receive the dividend on 8 January 2019.

In addition, the company's board has announced an additional USD10bn of treasury stock purchases with no time limit for completion. It has signed a USD5bn accelerated share repurchase programme under its expanded authorization.